For laboratory research use only. Not for human consumption.
Free cold-chain shipping over $200 CAD · Ships from Kelowna, BC

Lumera Labs Journal · Compendium

Ipamorelin: selective ghrelin-receptor agonist research

Published 2025-09-14 · Lumera Labs Editorial · Kelowna, BC

Short answer. Ipamorelin is a 5-residue synthetic selective agonist of the ghrelin receptor (GHS-R1a) with no measurable activity at the cortisol-releasing or prolactin-releasing axes that some earlier GHS-class peptides engaged. Lumera ships HPLC-verified Ipamorelin from $15 CAD.

Sequence

Ipamorelin is a pentapeptide: H-Aib-His-D-2-Nal-D-Phe-Lys-NH₂, where Aib is α-aminoisobutyric acid and 2-Nal is 2-naphthylalanine. Mass 711.86 Da. The use of two non-natural residues (Aib and 2-Nal) plus D-amino-acids drives selectivity for GHS-R1a over GHS-R1b and the off-target receptors that GHRP-2 and GHRP-6 engage.

Why selectivity matters

Earlier ghrelin-receptor agonists in the GHRP series (GHRP-6, GHRP-2, hexarelin) showed cross-reactivity with the cortisol-releasing axis and the prolactin-releasing axis at typical research-effective concentrations. Ipamorelin's selectivity profile means in-vitro experiments isolating GHS-R1a effects don't carry the same confound load.

Reference-grade quality criteria

  • RP-HPLC purity ≥ 99% at 220 nm.
  • ESI-MS at theoretical mass 711.86 Da ± 0.3 Da.
  • Stereochemistry verification: D-Phe and D-Nal residues confirmed by chiral HPLC.
  • Net peptide content ≥ 85% by AAA.

Common in-vitro applications

Pituitary GH-release assays, GHS-R1a binding affinity (low-nanomolar in published assays), comparative pharmacology against the GHRP series, downstream calcium-flux signaling readouts. Ipamorelin is also used as a GHS-R-selective control alongside GHRP-2 and GHRP-6 to dissect off-target effects.

Reconstitution

Highly water-soluble. Reconstitute a 5 mg vial with 1.0 mL bacteriostatic water for 5 mg/mL stock. Dissolves immediately. Stable 28 days at 2–8 °C; longer storage as −80 °C aliquots.

Stack research with CJC-1295

Ipamorelin is commonly studied alongside CJC-1295 (the GHRH-analog side of the growth-axis pair) to demonstrate the GHRH+GHS synergy in receptor co-engagement work. CJC + Ipamorelin pre-blend from $40 CAD; or source the two separately for independent dose-response curves.

Lumera Labs ships HPLC-verified Ipamorelin cold-chain across Canada from $15 CAD. View Ipamorelin on the catalog →


Frequently asked questions

How does Ipamorelin differ from GHRP-2?

Ipamorelin is selective for GHS-R1a; GHRP-2 has additional cortisol- and prolactin-axis activity at typical research concentrations. The selectivity makes Ipamorelin a cleaner tool for dissecting GHS-R1a-specific effects.

Why are non-natural residues used?

Aib (α-aminoisobutyric acid) and 2-Nal (2-naphthylalanine) plus D-amino-acid substitutions drive both selectivity and protease resistance. Native L-amino acids in the same positions would be less selective and more degradation-prone.

What is Ipamorelin's molecular weight?

711.86 Da. ESI-MS confirmation should be within 0.3 Da on a competent COA.

Storage protocol?

Lyophilized at −20 °C, sealed under nitrogen. After reconstitution, 2–8 °C for 28 days or −80 °C aliquots.

Where to source Ipamorelin in Canada?

Lumera Labs at /products/ipamorelin/ from $15 CAD per 5 mg vial; HPLC-verified, Janoshik-tested, cold-chain shipped from Kelowna.


Disclaimer: All Lumera Labs products are supplied for laboratory research use only. They are not approved by Health Canada for human consumption, therapy, or diagnosis. See our research-use declaration for full terms.

Browse the catalog →